 Home > Active Ingredient News > Immunology News > Br J Dermatol: Is heat shock protein 90 inhibition a relevant therapeutic strategy for psoriasis?

Br J Dermatol: Is heat shock protein 90 inhibition a relevant therapeutic strategy for psoriasis?

 Last Update: 2022-08-11
 Source: Internet
 Author: User

Tags

therapeutic

500 mg benadryl

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

In recent decades, several targeted therapies -- biologics and small molecules -- have been successfully developed and approved for the treatment of moderate-to-severe psoriasis vulgar.

In this issue of the BMJ, Bregnhøj et al report results from a proof-of-concept, phase Ib study investigating the safety of the novel HSP90 inhibitor RGRN-305 in 11 patients with plaque psoriasis and effectiveness for 12 wee.

The authors also performed skin transcriptome analysis using microarrays, which showed early and sustained reduction of pathophysiologically significant inflammatory transcripts, including IL36G and CXCL8, and delayed downregulation of IL23/STAT3-driven activity in clinical responde.

NLRP3 gene polymorphisms have been reported to increase the risk of psoriasis in Swedes, but evidence for a central role of the NLRP3 inflammasome in human psoriasis is still lacki.

immunity

Taken together, these results still herald a new paradigm for the treatment of psorias.

precise

Source: Bachelez H, Is heat shock protein 90 inhibition a relevant treatment strategy for psoriasis? Br J Dermatol 2022 05;186(5)

Bachelez H, Is heat shock protein 90 inhibition a relevant treatment strategy for psoriasis? Br J Dermatol 2022 05;186(5)

leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Top Quality 99.9% Ritlecitinib Tosylate Immunoregulation API & Inflammation Inhibitor

CAS No.: 2192215-81-7

Pharmacy Grade; Food Grade

$200-250/G FOB

β-Alanine107-95-9

CAS No.: 107-95-9

$1-1.1/KG FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.